Vir Biotechnology Rebuild Centers On AI-Driven Drug Discovery Platform
Vir Biotechnology is using AI-driven discovery and protein engineering to expand its oncology pipeline, with a recent Astellas deal reinforcing its platform strategy.
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 8
Vir Biotechnology is using AI-driven discovery and protein engineering to expand its oncology pipeline, with a recent Astellas deal reinforcing its platform strategy.
Abbott secured FDA clearance and CE Mark for its Ultreon 3.0 AI-powered OCT platform, designed to guide coronary interventions with real-time imaging insights.
The company says its CeeCee system will handle 25% of calls and automate up to 80% of intake documents by 2026.
Ochsner Health joins a $15 million American Heart Association network to use AI in scaling echocardiography screening for early detection of rheumatic heart disease.
Prezent introduced Prezent Vivo, combining AI and domain experts to deliver compliant life sciences communications across the full product lifecycle.
Johnson & Johnson is using AI to expand candidate volume in a system where most drugs do not survive.
SimonMed selects AIRS Medical’s SwiftMR to reduce MRI scan times and improve image quality across its nationwide imaging network.
CMS enables direct Medicare enrollment for tech-enabled care under ACCESS Model, with Innovaccer among first cohort ahead of July 2026 launch.
Spring Health launches Guide, an AI-led mental health experience designed to improve engagement, accelerate care, and deliver measurable clinical outcomes.
Children’s National Hospital is using machine learning to predict emergency department crowding, helping clinicians allocate staff earlier and reduce risks for high-acuity pediatric patients.
NewYork-Presbyterian and collaborators released EchoNext-Mini, an open-source ECG-based AI model and dataset, enabling broader research into structural heart disease screening.
Tolmar outlines a risk-based approach to AI adoption, focusing on data foundations, governance, and workflow redesign in regulated drug development.
The April 2026 Warning Letter may represent the first enforcement action specifically citing AI use in pharmaceutical manufacturing operations as non-compliant.
Aidoc and Sol Radiology deploy FDA-cleared clinical AI across hospitals and outpatient centers to improve imaging workflows and speed up patient care.
Banner Thunderbird Medical Center becomes first in Western U.S. to use a robotic digital microscope for brain tumor surgery, focusing on precision and surgeon ergonomics.
The Dells’ $750M investment will build an AI-native hospital and research campus in Austin, integrating care, computing, and MD Anderson cancer services.
UnitedHealth Group raised its 2026 outlook after a Q1 earnings beat, while committing $1.5 billion to AI tied to cost control and administrative efficiency.
The AI found a structural pattern that human researchers were not looking for because they did not know it existed.
Ellen Kelsay, CEO of Business Group on Health, warns employer healthcare costs will rise 9% in 2026, speaking at a Transcarent-led session on rising cost pressures.
The Nature Conservancy report shows how AI systems convert wildlife migration data into real-time conservation actions and planning decisions.